Genetic screening is used to identify mutations in the BRCA1 and BRCA2 genes and can be a great tool, particularly for women with a family history of breast cancer. However, genetic screening is expensive and these genes only account for 15-20% of all breast cancers. 89% of breast cancer occurs in women with no family history.